Sign In  |  Register  |  About Walnut Creek Guide  |  Contact Us

Walnut Creek, CA
September 01, 2020 1:43pm
7-Day Forecast | Traffic

  • Search Hotels in Walnut Creek Guide

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

SPDR Series Trust SPDR S&P Biotech ETF (NY: XBI )

87.97 +0.08 (+0.09%)
Official Closing Price Updated: 8:00 PM EST, Jan 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about SPDR Series Trust SPDR S&P Biotech ETF

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Healthcare And Biotech Stocks Review: Q1 2024 Performance
We just had one of the best first quarters in recent market history since Q1 in 2019 when the market was up 13%. But changes in sector performance may be coming. The S&P 500 was up 10% showing a slight... 
Via Talk Markets
Topics Stocks
Exposures US Equities
2 Top Biotech Buyout Candidates
Investors who are adventurous, have a high-risk tolerance, and are home run hitters may opt for biotech stocks. Investors in this group may want to hone in on stocks that have the potential to be... 
Via Talk Markets
3 Top ETFs I Plan to Buy in April
These ETFs are easy, low-cost ways to invest in certain themes. 
Via The Motley Fool
Topics ETFs
AskSlim Market Week - Friday, March 28
An analysis and commentary on the financial markets. 
Via Talk Markets
3 Biotech Stocks to Buy on the Dip: March 2024
Some of the best opportunities can be found in dips in some of the top biotech stocks to buy. In fact, here are three. 
Via InvestorPlace
Tuesday Talk: Big-Tech Under Attack
On Thursday the Justice Dept. filed an antitrust suit against Apple. The suit joins two others already filed against Google. How much this will affect the market in the long run is up for grabs. 
Via Talk Markets
Biotechnology And Healthcare, A Bit Of A Lull
Strong momentum of Tech and Chip stocks may be too good of a distraction for biotech investors. 
Via Talk Markets
3 Biotech ETFs Overdue for a Bounce
The biotech ETFs have been under serious pressure in recent years. Newfound momentum and looming lower rates could spark a comeback. 
Via InvestorPlace
Topics ETFs
It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility
Biotech is in a bull market aș measured by 2023 trends with a double testing of lows on 11/23. 
Via Talk Markets
Are We Listening To The Market's Message?
This week's video features chart/fact-based Q & A covering major stock market indexes, ETFs, the economy, homebuilders, regional banks, semiconductors, value stocks, energy stocks, biotech, and more. 
Via Talk Markets
Topics ETFs Economy
Exposures Economy
“Advance Is Advancing” Stock Market (And Sentiment Results)…
Commentary on the stock market, economy, inflation, biotech, and auto sales, as well as a deep dive into Advance Auto Parts. 
Via Talk Markets
Topics Economy
Exposures Economy Interest Rates
Biotech Stocks Surge To Start 2024: 'Charts Look Great,' But Will The Trend Continue?
The biotech sector has been surging in recent months, reawakening from a period of underperformance that followed the highs of 2021. David Prince, professional trader at T3 Trading Group, joined... 
Via Benzinga
TG Therapeutics Soars On In-Line Report; Is The Biotech Rally Buoying Shares?
The company reported in-line sales for the fourth quarter, but shares soared by double digits. 
Via Investor's Business Daily
Opportunities For Investors Beyond AI And Nvidia – Biotech Breaks Out, New GDP Data Shows Inflation Pressure
To gain an edge, this is what you need to know today. 
Via Benzinga
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Interest Rates
ETF Theme: Range-Bound
Here is the fund for the emerging markets, which is not only range-bound but seems to be following a regular time pattern. 
Via Talk Markets
Topics ETFs
Healthcare Stocks Are Looking Better But What About Biotech?
Large cap biopharmacuiticals remain a core holding for growth and value despite political cross-currents on drug pricing. 
Via Talk Markets
Favoring IWM, XBI, And KRE
It's time to employ ratios. Just like I utilize sector ratios such as XLF to XLU, XLY to XLP, or SPY to TLT, this is the time to look at IWM in comparison to the SPY. 
Via Talk Markets
Sunday ETF Review, Feb. 4, 2024
Examining my 
Via Talk Markets
Topics ETFs
Biotech And Medtech Portfolio Notes On A Fed Day
The Fed held rates keeping their future options flexible with no expectations for future cuts. The market did not like it and sold off with the Russell 2000 down 2.45% and the NASDAQ down 2.23% 
Via Talk Markets
Topics Economy
Exposures Interest Rates
3 Biotech Stocks with Potential for Major Medical Breakthroughs in 2024
There are several potential biotech breakthroughs likely to occur in 2024, and these three biotech stocks could see substantial gains 
Via InvestorPlace
Momentum Shifts Back To Tech Stocks As Healthcare Lags In 2024
Small Cap traders are taking a break in 2024 as XBI is down 2.51% YTD. 
Via Talk Markets
Biotech Playbook: Small Caps Show Momentum Peaking During
The momentum of selected stocks was strong up until early January was encouraging but we need less volatility in period ahead to conform a new bull market. 
Via Talk Markets
5 Biotech Stocks That Should Be On Investors' Radar As JPMorgan Healthcare Conference Gets Underway Monday
The rebound by biopharma stocks in 2023 and the pickup in M&A news flow makes the 2024 JPMorgan Healthcare conference even more interesting. 
Via Benzinga
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain. 
Via Investor's Business Daily
2023 in Review: Key Stock Trends and Sector Shifts Unveiled
Investors would be smart to pay attention to these stock trends, many of which are taking hold as the New Year begins. 
Via InvestorPlace
Satori Fund's Dan Niles Names Amazon, Meta Top Stocks To Own In 2024
Satori Fund founder and portfolio manager Dan Niles is out with his top stock picks for 2024 and two Magnificent 7 names are at the top of the list. 
Via Benzinga
Wall Street Thinks These 2 Biotech Stocks Could Soar in 2024
These two biotech stocks sport notable 12-month price targets. However, they are also uber-risky. 
Via The Motley Fool
3 Thematic Growth ETFs to Load Up on Right Now
These three thematic ETFs could be potent growth vehicles in years to come. 
Via The Motley Fool
Topics ETFs
Small Caps Are On A Tear Including Speculative Biotechs
So far 2023 is going well with our game plan -an end-of-year seasonal rally coupled with a run in speculative biotechs driven by innovation. 
Via Talk Markets
US Stocks Eye 7-Day Winning Streak As Mortgage Rates Fall Below 7%, Yields Tumble: What's Driving Markets Thursday?
It’s shaping up to be a positive Thursday on Wall Street, with risk sentiment remaining robust after the Federal Reserve effectively opened the door to rate cuts in 2024. 
Via Benzinga
Topics Economy
Exposures Interest Rates
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 WalnutCreekGuide.com & California Media Partners, LLC. All rights reserved.